This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Articles

Clinical Experience With Insulin Resistance, Diabetic Ketoacidosis, and Type 2 Diabetes Mellitus in Patients Treated With Atypical Antipsychotic Agents

David C. Henderson

Published: January 14, 2001

Article Abstract

Numerous reports have associated atypical antipsychotic agents with hyperglycemia, diabetesmellitus, and diabetic ketoacidosis. Although the mechanisms are poorly understood, clinical experiencesuggests that these adverse effects are major areas of concern and require attention by the psychiatricteam and primary care clinicians. This article discusses my clinical experience with glucosemetabolism impairment related to treatment with antipsychotic medications.


Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 62

Quick Links: Metabolic Disorder , Side Effects-Medication

Sign-up to stay
up-to-date today!

SUBSCRIBE

Already registered? Sign In

Case Report

Safety and Tolerability of Concomitant Intranasal Esketamine Treatment With Irreversible, Nonselective MAOIs: A Case Series

Three cases suggest that concomitant use of intranasal esketamine with an irreversible, nonselective MAOI is safe in...

Read More...